National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life

Clinical trial NCT02925338 · COMPLETED

Trial details

NCT number: NCT02925338
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Crohn Disease Ulcerative Colitis Rheumatoid Arthritis Ankylosing Spondylitis Psoriatic Arthritis

Start date: 2016-10-19
Primary completion: 2021-04-12
Enrollment: 1431

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.